Houda serves on the Clinical Pharmacogenetics Implementation Consortium (CPIC) Scientific Advisory Board and is an active member of the Pharmacogene Variation Consortium (PharmVar). She is involved with several pharmacogenomics working groups and committees aimed at standardizing pharmacogenomic testing modalities and at facilitating their adoption by the clinical community. Houda has overseen the development of pharmacogenetic product line extensions from inception to delivery and spearheaded the operational efforts for translating scientific requirements into technology solutions.
Sign up to view 1 direct report
Get started